Suppr超能文献

经输尿管镜活检上尿路尿路上皮癌后膀胱复发:一项具有克隆性基因组评估的多中心观察性研究。

Urinary bladder recurrences following ureteroscopic biopsies of upper tract urothelial cancers: a multi-centre observational study with genomic assessment for clonality.

机构信息

College of Medicine and Veterinary Medicine, The University of Edinburgh, Edinburgh, UK.

Department of Urology, Pilgrim Hospital, United Lincolnshire NHS Trust, England, UK.

出版信息

Scott Med J. 2023 Feb;68(1):4-13. doi: 10.1177/00369330221134233. Epub 2022 Dec 28.

Abstract

BACKGROUND AND AIMS

Urinary bladder recurrences (UBRs) after radical nephroureterectomy (RNUx) are a known challenge in patients with upper-tract urothelial cancers (UTUCs). We aim to assess factors associated with UBR and clonal-relatedness with resected UTUC.

METHODS

Patients who underwent RNUx for UTUC between 1998 and 2015 in five institutions were identified. Clonal relatedness between primary UTUC and subsequent UBR in a sub-cohort was assessed using next-generation sequencing. A Kaplan-Meier curve was used to assess differences in UBR between two groups (with or without ureteroscopic biopsy).

RESULTS

Of 267 patients with complete records, 73 (27.3%) had UBR during follow-up. The five-year UBR-free survival in all patients was 64.7%. The five-year UBR-free-survival was inferior in patients who underwent URS biopsy compared with patients who did not undergo ureteroscopic biopsy (49.9% vs 76.4%,  < 0.001). History of bladder tumour (HR, 95% CI; 2.94, 1.73-5.00,  < 0.001), ureteroscopic biopsy (HR, 95% CI; 2.21, 1.38-3.53,  = 0.001) and preoperative urine cytology ≥C3 (HR, 95% CI; 2.06, 1.24-3.40,  = 0.005) were independently associated with UBR. Patients with ureteroscopic biopsy (n = 3/5) showed identical mutational changes for common genes ( and ) between primary UTUC and subsequent UBR.

CONCLUSIONS

Ureteroscopic biopsy of UTUC is a significant risk factor for UBR. Qualitative clonality assessment showed identical mutational signatures between primary UTUC and UBR.

摘要

背景与目的

根治性肾输尿管切除术(RNUx)后发生的尿路上皮膀胱癌(UBR)是上尿路尿路上皮癌(UTUC)患者面临的一个已知挑战。本研究旨在评估与 UBR 相关的因素以及与切除的 UTUC 的克隆相关性。

方法

确定了 1998 年至 2015 年在五个机构接受 RNUx 治疗的 UTUC 患者。在一个亚组中,使用下一代测序评估原发性 UTUC 和随后的 UBR 之间的克隆相关性。采用 Kaplan-Meier 曲线评估两组(行或不行输尿管镜活检)之间 UBR 的差异。

结果

在有完整记录的 267 例患者中,73 例(27.3%)在随访期间发生 UBR。所有患者的 5 年 UBR 无复发生存率为 64.7%。与未行输尿管镜活检的患者相比,行输尿管镜活检的患者 5 年 UBR 无复发生存率更差(49.9%比 76.4%, < 0.001)。膀胱癌病史(HR,95%CI;2.94,1.73-5.00, < 0.001)、输尿管镜活检(HR,95%CI;2.21,1.38-3.53, = 0.001)和术前尿细胞学≥C3(HR,95%CI;2.06,1.24-3.40, = 0.005)与 UBR 独立相关。行输尿管镜活检的患者(n=3/5)在原发性 UTUC 和随后的 UBR 之间显示出常见基因(和)相同的突变变化。

结论

UTUC 的输尿管镜活检是 UBR 的一个重要危险因素。定性克隆性评估显示原发性 UTUC 和 UBR 之间存在相同的突变特征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验